Ironwood Pharmaceuticals reported $396.25M in Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Ardelyx ARDX:US USD 26.71M 170K
Astellas Pharma 4503:JP JPY 329.15B 41.15B
AstraZeneca AZN:LN USD 29.23B 67M
Astrazeneca AZN:US USD 29.23B 67M
Charles River Laboratories CRL:US USD 2.71B 227.93M
Coherus Biosciences CHRS:US USD 473.67M 3.17M
Emergent Biosolutions EBS:US USD 1.41B 352.5M
Esperion Therapeutics ESPR:US USD 259.9M 412K
Exact Sciences EXAS:US USD 2.25B 981K
Halozyme Therapeutics HALO:US USD 1.51B 1.63M
Intercept Pharmaceuticals ICPT:US USD 332.67M 365K
Ironwood Pharmaceuticals IRWD:US USD 396.25M 401K
Karyopharm Therapeutics KPTI:US USD 302.82M 69K
Lexicon Pharmaceuticals LXRX:US USD 48.58M 24.8M
Moderna Inc MRNA:US USD 1.07B 73M
Pacira Pharmaceuticals PCRX:US USD 689.47M 58.4M
Ptc Therapeutics PTCT:US USD 1.35B 289.13M
Puma Biotechnology PBYI:US USD 98.31M 313K
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
Takeda 4502:JP JPY 4.29T 449.74B